We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 10, 2022

Baseline Imaging-Derived Predictive Factors of Response Following [177Lu]Lu-PSMA-617 Therapy in Patients With mCRPC



Additional Info

Baseline Imaging Derived Predictive Factors of Response Following [177Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis
Biomedicines 2022 Jul 01;[EPub Ahead of Print], ECA van der Sar, AJS Kühr, SC Ebbers, AM Henderson, B de Keizer, MGEH Lam, AJAT Braat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading